SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001088875-24-000040
Filing Date
2024-01-29
Accepted
2024-01-29 10:49:28
Documents
1

Document Format Files

Seq Description Document Type Size
1 Moderna29122023.txt SC 13G/A 9666
  Complete submission text file 0001088875-24-000040.txt   11313
Mailing Address CALTON SQUARE 1 GREENSIDE ROW EDINBURGH X0 EH13AN
Business Address CALTON SQUARE 1 GREENSIDE ROW EDINBURGH X0 EH13AN 00441312752000
BAILLIE GIFFORD & CO (Filed by) CIK: 0001088875 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0
Type: SC 13G/A

Mailing Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139
Business Address 200 TECHNOLOGY SQUARE CAMBRIDGE MA 02139 6177146500
Moderna, Inc. (Subject) CIK: 0001682852 (see all company filings)

IRS No.: 813467528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90749 | Film No.: 24571178
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)